XML 39 R27.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Assumptions for options granted
          
   2021   2020 
Expected volatility   93.03% - 99.32%    74.16% - 115.78% 
Expected term   5 - 7 Years    5 - 7 Years 
Risk-free interest rate   1.25% - 1.38%    0.37% - 1.79% 
Weighted average FV  $19.55   $12.38 
Schedule of option activity
             
  

Number of

Options

 

Weighted

Average

Exercise

Price

 

Weighted

Average

Remaining

Contractual Life

Outstanding at December 31, 2019   239,704   $9.25    
Granted   105,604    15.63    
Exercised   (3,000)   4.09    
Forfeited   (500)   5.27    
Outstanding at December 31, 2020   341,808    11.27    
Granted   43,300    24.63    
Exercised   (97,192)   13.28    
Forfeited   (24,483)   23.84    
Outstanding at December 31, 2021   263,433   $11.56   7.24 Years
Exercisable at December 31, 2021   155,402   $7.04   6.12 Years
Warrant activity
         
  

Number of

Warrants

   Weighted Average Exercise Price 
Outstanding at December 31, 2019  2,535,790   $6.41 
Exercised  (1,570,206)  $6.47 
Outstanding at December 31, 2020  965,584   $6.33 
Exercised  (445,926)  $6.40 
Outstanding at December 31, 2021  519,658   $6.30 
Exercisable at December 31, 2021  519,658   $6.30 
Restricted Stock Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of restricted stock award activity

Schedule of restricted stock award activity

  

Nonvested

Shares

 

Weighted-

Average Grant-

Date Fair Value

Nonvested at December 31, 2019  44,437   $5.63 
Granted  61,908    12.44 
Vested  (59,782)   7.51 
Nonvested at December 31, 2020  46,563    12.28 
Granted  20,444    31.41 
Vested  (40,513)   18.32 
Forfeited  (12,825)   14.95 
Nonvested at December 31, 2021  13,669   $20.45